Biotie Therapies Corp Company Profile (NASDAQ:BITI)

About Biotie Therapies Corp

Biotie Therapies Corp logoBiotie Therapies Corp is a Finland-based drug development company focused on developing products for neurodegenerative and psychiatric disorders. The Company's lead market product is Selincro (nalmefene), a therapeutic for alcohol dependence that is rolled out across Europe by its partner Lundbeck. Its product pipeline includes tozadenant, a therapeutic for Parkinson's disease that is in Phase Three development; and two additional compounds in Phase Two development that treat cognitive disorders, namely: SYN120, an orally administered compound therapeutic for Parkinson's disease dementia, and BTT1023, a human monoclonal antibody targeting compound therapeutic for primary sclerosing cholangitis. The Company operates as a subsidiary of Biotie Therapies Corp.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BITI
  • CUSIP:
Key Metrics:
  • Previous Close: $25.80
  • 50 Day Moving Average: $26.42
  • 200 Day Moving Average: $22.73
  • 52-Week Range: $12.43 - $27.96
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.87
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to Biotie Therapies Corp:

Analyst Ratings

Consensus Ratings for Biotie Therapies Corp (NASDAQ:BITI) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $25.60 (0.78% downside)

Analysts' Ratings History for Biotie Therapies Corp (NASDAQ:BITI)
Show:
DateFirmActionRatingPrice TargetDetails
3/21/2016Royal Bank of CanadaDowngradeOutperform -> Sector Perform$35.00 -> $25.60View Rating Details
1/19/2016Roth CapitalDowngradeBuy -> NeutralView Rating Details
1/19/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
7/6/2015JMP SecuritiesInitiated CoverageOutperform$32.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Biotie Therapies Corp (NASDAQ:BITI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/20/2015($1.10)($1.77)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biotie Therapies Corp (NASDAQ:BITI)
Current Year EPS Consensus Estimate: $-3.30 EPS
Next Year EPS Consensus Estimate: $-2.91 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.87)($0.87)($0.87)
Q2 20161($0.87)($0.87)($0.87)
Q3 20161($0.87)($0.87)($0.87)
Q4 20161($0.87)($0.87)($0.87)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Biotie Therapies Corp (NASDAQ:BITI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biotie Therapies Corp (NASDAQ:BITI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Biotie Therapies Corp (NASDAQ:BITI)
DateHeadline
finance.yahoo.com logoACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST (NASDAQ:BITI)
finance.yahoo.com - October 27 at 4:07 PM
finance.yahoo.com logoARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED (NASDAQ:BITI)
finance.yahoo.com - September 26 at 8:36 AM
finance.yahoo.com logoBiotie Therapies Corp.'s Interim Report for the reporting period January 1 - June 30, 2016 (NASDAQ:BITI)
finance.yahoo.com - July 28 at 2:02 AM
finance.yahoo.com logoCHANGES IN THE MANAGEMENT TEAM (NASDAQ:BITI)
finance.yahoo.com - June 29 at 2:16 AM
finance.yahoo.com logoChange in Biotie Therapies' Financial Reporting Calendar 2016 (NASDAQ:BITI)
finance.yahoo.com - June 21 at 10:02 AM
finance.yahoo.com logoTRUSTEE APPOINTED FOR THE REDEMPTION PROCEEDINGS CONCERNING BIOTIE'S MINORITY SHARES (NASDAQ:BITI)
finance.yahoo.com - June 10 at 1:02 AM
capitalcube.com logoBiotie Therapies Oyj :BITI-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 (NASDAQ:BITI)
www.capitalcube.com - May 26 at 11:10 AM
finance.yahoo.com logoNORDEA BANK FINLAND PLC'S MARKET-MAKING FOR BIOTIE THERAPIES CORP.'S SHARE ENDS (NASDAQ:BITI)
finance.yahoo.com - May 18 at 11:22 AM
finance.yahoo.com logo4:11 am Biotie Therapies reports Q1 results (NASDAQ:BITI)
finance.yahoo.com - May 12 at 4:11 AM
finance.yahoo.com logoBiotie Interim Report 1 January - 31 March 2016 (NASDAQ:BITI)
finance.yahoo.com - May 12 at 2:03 AM
finance.yahoo.com logoRESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. AND ORGANIZATION OF THE BOARD (NASDAQ:BITI)
finance.yahoo.com - May 3 at 9:33 AM
finance.yahoo.com logoFINAL RESULTS OF THE SUBSEQUENT OFFER PERIOD OF ACORDA'S TENDER OFFER FOR ALL SECURITIES IN BIOTIE (NASDAQ:BITI)
finance.yahoo.com - May 2 at 9:43 AM
finance.yahoo.com logoFinal Results of the Subsequent Offer Period of Acorda Therapeutics' Tender Offer for All of the Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. (NASDAQ:BITI)
finance.yahoo.com - May 2 at 9:02 AM
finance.yahoo.com logoACORDA THERAPEUTICS TO COMMENCE A COMPULSORY REDEMPTION PROCEEDING IN RESPECT OF THE REMAINING BIOTIE THERAPIES CORP. SHARES (NASDAQ:BITI)
finance.yahoo.com - April 20 at 9:52 AM
finance.yahoo.com logoCompletion of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. and Matters Related Thereto (NASDAQ:BITI)
finance.yahoo.com - April 18 at 4:01 PM
finanznachrichten.de logoBiotie Therapies Oyj: FINAL RESULTS OF ACORDA'S TENDER OFFER AND COMMENCEMENT OF A SUBSEQUENT OFFER PERIOD (NASDAQ:BITI)
www.finanznachrichten.de - April 13 at 2:35 PM
finance.yahoo.com logoFINAL RESULTS OF ACORDA'S TENDER OFFER AND COMMENCEMENT OF A SUBSEQUENT OFFER PERIOD (NASDAQ:BITI)
finance.yahoo.com - April 13 at 10:13 AM
finance.yahoo.com logoFinal Results of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. and Commencement of a Subsequent Offer (NASDAQ:BITI)
finance.yahoo.com - April 13 at 9:00 AM
finance.yahoo.com logoDisclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (NASDAQ:BITI)
finance.yahoo.com - April 12 at 9:22 AM
finance.yahoo.com logoINVITATION TO THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. (NASDAQ:BITI)
finance.yahoo.com - April 12 at 2:02 AM
finance.yahoo.com logoACORDA ANNOUNCES PRELIMINARY TENDER OFFER RESULTS AND ACCEPTANCE OF THE SECURITIES IN BIOTIE TENDERED IN TENDER OFFER (NASDAQ:BITI)
finance.yahoo.com - April 11 at 10:02 AM
finance.yahoo.com logoAcorda Therapeutics Announces Preliminary Tender Offer Results and Acceptance of the Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. Tendered in Tender Offer (NASDAQ:BITI)
finance.yahoo.com - April 11 at 8:59 AM
News IconRBC Capital Downgrades Biotie Therapies Oyj (ADR) to Sector Perform with Price Target $25.60 - Street Edition (NASDAQ:BITI)
www.streetedition.net - March 27 at 1:17 PM
finance.yahoo.com logoBIOTIE THERAPIES CORP. Financials (NASDAQ:BITI)
finance.yahoo.com - March 26 at 1:04 PM
globenewswire.com logoACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER ... - GlobeNewswire (press release) (NASDAQ:BITI)
globenewswire.com - March 23 at 1:00 PM
News IconRevenue Update on Biotie Therapies Oyj (ADR)(NASDAQ:BITI) - Street Edition (NASDAQ:BITI)
www.streetedition.net - March 23 at 1:00 PM
capitalcube.com logoBiotie Therapies Oyj :BITI-US: Earnings Analysis: Q4, 2015 By the Numbers (NASDAQ:BITI)
www.capitalcube.com - March 23 at 10:18 AM
capitalcube.com logoBiotie Therapies Oyj :BITI-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:BITI)
www.capitalcube.com - March 22 at 2:06 PM
News IconACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER ... - PharmiWeb.com (press release) (NASDAQ:BITI)
www.pharmiweb.com - March 22 at 1:39 PM
finance.yahoo.com logoACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER ON 22 MARCH 2016 (NASDAQ:BITI)
finance.yahoo.com - March 22 at 8:22 AM
finance.yahoo.com logoAcorda Therapeutics Supplements the Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Co (NASDAQ:BITI)
finance.yahoo.com - March 22 at 8:03 AM
finance.yahoo.com logoBiotie's Financial Statement Report and Corporate Governance Statement 2015 published (NASDAQ:BITI)
finance.yahoo.com - March 22 at 4:02 AM
News IconBiotie Therapies Oyj (ADR) (BITI) is Downgraded by RBC Capital Mkts to Sector Perform, Lowers Price Target to $ 25.60 - Los Angeles Mirror (NASDAQ:BITI)
www.losangelesmirror.net - March 21 at 1:54 PM
finance.yahoo.com logoBiotie Therapies downgraded by RBC Capital Mkts (NASDAQ:BITI)
finance.yahoo.com - March 21 at 6:11 AM
finance.yahoo.com logoACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER ON 18 MARCH 2016 (NASDAQ:BITI)
finance.yahoo.com - March 18 at 9:43 AM
finance.yahoo.com logoAcorda Therapeutics Supplements Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies on 18 (NASDAQ:BITI)
finance.yahoo.com - March 18 at 9:03 AM
finance.yahoo.com logoBiotie Financial Statement Release 2015 (NASDAQ:BITI)
finance.yahoo.com - March 18 at 3:03 AM
finance.yahoo.com logoTHE FINNISH FINANCIAL SUPERVISORY AUTHORITY HAS APPROVED THE TENDER OFFER DOCUMENT, ACORDA WILL COMMENCE THE VOLUNTARY PUBLIC TENDER OFFER ON 11 MARCH 2016 (NASDAQ:BITI)
finance.yahoo.com - March 10 at 10:47 AM
finance.yahoo.com logoAcorda Therapeutics, Inc. Will Commence the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. on 11 March 2016 (NASDAQ:BITI)
finance.yahoo.com - March 10 at 8:40 AM
finance.yahoo.com logoCHANGE IN THE TIME OF BIOTIE THERAPIES' ANNUAL GENERAL MEETING 2016 (NASDAQ:BITI)
finance.yahoo.com - March 4 at 11:42 AM
finance.yahoo.com logoAcorda Has Filed Tender Offer Document Relating to Public Tender Offer For Biotie Therapies with Finnish Financial Supervisory Authority (NASDAQ:BITI)
finance.yahoo.com - March 3 at 1:30 AM
finance.yahoo.com logoU.S. antitrust regulation waiting period relating to tender offer has expired (NASDAQ:BITI)
finance.yahoo.com - February 17 at 2:04 AM
finance.yahoo.com logoAcorda Announces Expiration of the Hart-Scott-Rodino Waiting Period for Its Tender Offer for Biotie Therapies (NASDAQ:BITI)
finance.yahoo.com - February 17 at 1:30 AM
finance.yahoo.com logoBiotie Therapies Soars on $363M Buyout Deal with Acorda (NASDAQ:BITI)
finance.yahoo.com - January 20 at 4:25 PM
finance.yahoo.com logoBiotie Therapies Soars on $363M Buyout Deal with Acorda (NASDAQ:BITI)
finance.yahoo.com - January 20 at 4:25 PM
finance.yahoo.com logoBiotie Therapies (BITI) Catches Eye: Stock Moves Up 86.5% (NASDAQ:BITI)
finance.yahoo.com - January 20 at 8:15 AM
finance.yahoo.com logoBiotie Therapies (BITI) Catches Eye: Stock Moves Up 86.5% (NASDAQ:BITI)
finance.yahoo.com - January 20 at 8:15 AM
finance.yahoo.com logoAcorda Therapeutics To Acquire Biotie Therapies To Boost Its Parkinson's Disease Therapeutic Development (NASDAQ:BITI)
finance.yahoo.com - January 19 at 9:40 AM
finance.yahoo.com logoAcorda Therapeutics To Acquire Biotie Therapies To Boost Its Parkinson's Disease Therapeutic Development (NASDAQ:BITI)
finance.yahoo.com - January 19 at 9:40 AM

Social

What is Biotie Therapies Corp's stock symbol?

Biotie Therapies Corp trades on the NASDAQ under the ticker symbol "BITI."

Where is Biotie Therapies Corp's stock going? Where will Biotie Therapies Corp's stock price be in 2017?

1 equities research analysts have issued 1-year target prices for Biotie Therapies Corp's stock. Their forecasts range from $25.60 to $25.60. On average, they anticipate Biotie Therapies Corp's stock price to reach $25.60 in the next twelve months.

How do I buy Biotie Therapies Corp stock?

Shares of Biotie Therapies Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Biotie Therapies Corp stock cost?

One share of Biotie Therapies Corp stock can currently be purchased for approximately $25.80.

Biotie Therapies Corp (NASDAQ:BITI) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Biotie Therapies Corp (NASDAQ:BITI)

Earnings History Chart

Earnings by Quarter for Biotie Therapies Corp (NASDAQ:BITI)

Dividend History Chart

Dividend Payments by Quarter for Biotie Therapies Corp (NASDAQ:BITI)

Last Updated on 2/25/2017 by MarketBeat.com Staff